文献速递湿疹皮炎与荨麻疹

新生儿期使用润肤剂预防特应性皮炎的随机对照研究(泰国)

Effects of an emollient application on newborn skin from birth for prevention of atopic dermatitis: a randomized controlled study in Thai neonates.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2021-09-30

该随机对照研究在泰国一家三级医院纳入高危新生儿,从出生后3周内开始给予润肤剂加护肤指导或仅护肤指导,随访6个月。润肤剂组特应性皮炎累积发病率显著降低(RR 0.39,95%CI 0.24-0.64,P<0.001),且发病更晚、严重度更低,但痱子及疑似皮肤感染更常见。

要点

  • 热带气候下高危新生儿按需使用润肤剂可显著降低6个月AD累积发病率。
  • 润肤剂组AD发病更晚且严重度更低,但痱子和疑似脓疱疮更常见。
  • 被动吸烟暴露与AD发生显著相关,孕期及出生后均如此。

核心结论

  • 在热带气候下,对高危新生儿按需(依据环境因素和皮肤干燥程度)而非每日使用润肤剂,可对AD预防提供显著益处。

研究设计与样本

  • 随机对照研究,在泰国一家三级医院进行,为期6个月。
  • 符合条件的新生儿随机分配至润肤剂加护肤指导组或仅护肤指导组,干预在出生后3周内开始。

主要发现

  • 润肤剂组6个月时AD累积发病率显著降低(相对风险0.39,95%CI 0.24-0.64,P<0.001)。
  • 润肤剂组AD发生更晚且严重度更低(P<0.001)。
  • 与中等依从性相比,低依从性与AD患者数量更少相关(P=0.008)。
  • 润肤剂组痱子等可能相关皮疹及疑似皮肤感染(如脓疱疮)更常见。
  • 孕期及出生后被动吸烟暴露与AD发生显著相关(P<0.001)。

临床怎么用

  • 在热带气候地区,可考虑对高危新生儿按需使用润肤剂以预防AD,而非每日使用。
  • 使用润肤剂时需监测痱子和皮肤感染等不良反应。
  • 评估AD风险时应关注被动吸烟暴露情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Enhancing the skin barrier in high-risk neonates by daily use of emollients during infancy might prevent atopic dermatitis (AD); however, there have been no studies on this topic in a country with a tropical climate. Climate may affect the results of the use of emollients in neonates for AD prevention and possible adverse cutaneous eruptions. OBJECTIVES: To test the hypothesis that emollients used during infancy can prevent AD in high-risk neonates in a country with a tropical climate and to evaluate other possible adverse cutaneous eruptions in this population. METHODS: This was a randomized controlled study in a tertiary care hospital with a 6 months' duration. Eligible neonates were randomly assigned to receive either emollient and skincare advice (emollient group) or skincare advice only (control group). The intervention was started within 3 weeks of birth. RESULTS: The emollient group showed a significant reduction in the cumulative incidence of AD at 6 months (relative risk, 0.39; 95% CI 0.24-0.64; P < 0.001). The emollient group started to develop AD later and had a lower severity of AD than the control group (P < 0.001). Compared to moderate adherence, low adherence to emollient application was associated with a lower number of patients with AD (P = 0.008). Potentially emollient-related cutaneous eruptions, such as miliaria, and suspected cutaneous infections, such as impetigo, were more frequent in the emollient group. Exposure to passive smoking showed a significant difference in the development of AD compared to non-smoking exposure, both during pregnancy and after the child's birth (P < 0.001). CONCLUSIONS: This study suggests that, in a tropical climate, emollient applied to the skin of at-risk neonates on an 'as needed' basis (depending on environmental factors, level of skin dryness), rather than on a 'daily basis', can provide a substantial benefit for AD prevention.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Techasatian L, Kiatchoosakun P. Effects of an emollient application on newborn skin from birth for prevention of atopic dermatitis: a randomized controlled study in Thai neonates. J Eur Acad Dermatol Venereol. 2021. PMID: 34545646. doi:10.1111/jdv.17675

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。